Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
How AI-driven platforms can save failing trials by using data to hone protocols, identify sub-populations with shared traits, and ensure the right patients are recruited to demonstrate success.
Failed clinical trials can cost sponsors more than a billion dollars, and waste years of time developing a drug that will never get to market.
However, these losses can now be mitigated through the use of artificial intelligence (AI) and machine learning-driven platforms that identify sub-populations of patients within a clinical trial who could respond positively to a treatment.
Find more valuable content here: Transforming clinical development with Artificial Intelligence
Sponsored content from IQVIA